NIH

Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface. Read More

Antacids that block a certain enzyme pose a risk for a common cardiac problem in premature infants. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

Children with autism spectrum disorder are better at perceiving the motion of certain objects than are typically developing children their age. Read More

A component of the extracellular matrix that surrounds cells plays a role in insulin resistance and may be a good therapeutic target. Read More

A high-salt diet worsens the carcinogenic effects of Helicobacter pylori, a bacterium that colonizes the stomachs of half of the world’s population. Read More

A “profile” of the genes and regulatory networks that govern early heart valve development lay the groundwork for generating valves from a patient’s own cells. Read More

Researchers at Vanderbilt University have received grant awards from the National Institutes of Health as part of the Autism Centers of Excellence (ACE) research program. The NIH announced grant awards of $100 million over five years to 11 centers nationwide, three of which feature projects from Vanderbilt Kennedy Center investigators, to further studies on autism treatment and intervention. Read More

An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus. Read More

Vanderbilt researchers have developed a novel algorithm to improve results from proteomic studies. Read More